ChrysCapital
Finance
Apis, ChrysCap co-investing in a private lender
London-based mid-market private equity firm Apis Partners, which is focused on financial services and technology segments, is...
Healthcare
ChrysCapital returns as investor in another pharma firm after taking it public
Homegrown private equity firm ChrysCapital has returned to invest in a pharmaceutical company that it had helped launch on the...
Healthcare
ChrysCapital set to reinvest in another pharmaceutical portfolio firm
Homegrown private equity firm ChrysCapital is in advanced talks to increase its stake in its oldest pharmaceutical portfolio company,...
Healthcare
ChrysCapital logs out of drugmaker with below-par returns
Homegrown private equity firm ChrysCapital has fully exited its more than seven-year-old investment in a pharmaceutical company...
Finance
KKR elevates two India executives as managing directors
Global alternative asset manager KKR & Co has promoted two India executives that it had hired just last year as ......
Finance
How ChrysCapital's partial exit from drugmaker panned out
ChrysCapital has sold another chunk of its stake in a Mumbai-based drugmaker, as the homegrown private equity firm positions itself...
Healthcare
How much did SAIF Partners, ChrysCapital make from stake sale in drugmaker?
Venture capital and growth-equity investor SAIF Partners as well as private equity firm ChrysCapital have sold stakes in an Indian...
Finance
Indian PE-VC funds draw record commitment from LPs in Q1 as dry powder hits $23 bn
Indian private equity and venture capital firms garnered a record investment commitment from Limited Partners (LPs) in the first...
Finance
Recent India PE exit returns beat top public market mutual funds: VCCircle study
A reasonable return from investments—the primary incentive for moneybags to open their sack—has long been seen as...
Healthcare
ChrysCap emerges as front runner to invest in Mumbai bulk-drugs maker
Homegrown private equity firm ChrysCapital has emerged as the primary suitor to clinch an investment in a Mumbai-based drug maker,...
